Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Research Grade Biosimilars

Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO) (HX959036)

Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)
Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)
Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)
Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)
Price(USD):
Spec:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HX959036
Description
Alnuctamab (HX959036) is a research-grade recombinant antibody targeting CD269. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivityHuman
ApplicationsELISA, Bioactivity: FCM, Functional assay, Research in vivo
Host speciesHuman
ClonalityMonoclonal
IsotypeIgG1;IgG1, Kappa;Lambda
Target B-cell maturation protein, BCM, BCMA, CD269, TNFRSF17, Tumor necrosis factor receptor superfamily member 17, CD3E, CD3e, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 epsilon chain, T3E
Endotoxin level < 10 EU/mg
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession Q02223 & P07766
Form Liquid
Storage buffer 0.01M PBS pH 7.4.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesTrivalentBispecific, CC-93269, EM-901, 2296827-07-9
BackgroundTeclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
Human IgG1 (E356D/M358L), kappa Recombinant Isotype Control Antibody (HyHEL-10) (HV080013)
Anti-LASV GPC Recombinant Antibody (Fab 37.7) (VK453013)
Images
  • Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)

    Bioactivity

    Detects Human CD269/TNFRSF17/BCMA in indirect ELISAs.

  • Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)

    SDS-PAGE

    SDS-PAGE for Anti-Human BCMA/TNFRSF17 & CD3 epsilon Bispecific Reference Antibody (Alnuctamab, RUO)

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: [email protected]

Distributor list